EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Pyroptosis and the fight against lung cancer

Jiwei Wang, Huiling Su, Min Wang, Richard Ward, Su An iD, Tian-Rui Xu iD

Medicinal Research Reviews · 2025-01 · 45 (1) · 5-28

DOI: 10.1002/med.22071 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, online erschienen am 12.08.2024. Verfasst von Jiwei Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Primate Biomedical Research, Kunming University of Science and Technology, Kunming, China. Hauptthemen laut MEDLINE: Pyroptosis, Lung Neoplasms. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 144 Literaturangaben. Gefördert von: National Natural Science Foundation of China (NSFC), Yunnan Major Scientific and Technological Projects, Key Fund of Yunnan Basic Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pyroptosis, a newly characterized type of inflammatory programmed cell death (PCD), is usually triggered by multiple inflammasomes which can recognize different danger or damage‐associated molecular patterns (DAMPs), leading to the activation of caspase‐1 and the cleavage of gasdermin D (GSDMD). Gasdermin family pore‐forming proteins are the executers of pyroptosis and are normally maintained in an inactive state through auto‐inhibition. Upon caspases mediated cleavage of gasdermins, the pro‐pyroptotic N‐terminal fragment is released from the auto‐inhibition of C‐terminal fragment and oligomerizes, forming pores in the plasma membrane. This results in the secretion of interleukin (IL)‐1β, IL‐18, and high‐mobility group box 1 (HMGB1), generating osmotic swelling and lysis. Current therapeutic approaches including chemotherapy, radiotherapy, molecularly targeted therapy and immunotherapy for lung cancer treatment efficiently force the cancer cells to undergo pyroptosis, which then generates local and systemic antitumor immunity. Thus, pyroptosis is recognized as a new therapeutic regimen for the treatment of lung cancer. In this review, we briefly describe the signaling pathways involved in pyroptosis, and endeavor to discuss the antitumor effects of pyroptosis and its potential application in lung cancer therapy, focusing on the contribution of pyroptosis to microenvironmental reprogramming and evocation of antitumor immune response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyroptosisLung NeoplasmsHumansAnimalsSignal TransductionInflammasomes

Stichwörter der Autor:innen

antitumor immunitygasderminsinflammasomelung cancerpyroptosis

Substanzen

Inflammasomes

Autor:innen und Institutionen

  • State Key Laboratory of Primate Biomedical Research, Kunming University of Science and Technology, Kunming, China.
  • Center for Pharmaceutical Sciences and Engineering, Kunming University of Science and Technology, Kunming, China.
  • Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, China.
  • Centre for Translational Pharmacology, Institute of Molecular Cell and Systems Biology, College of Medical, University of Glasgow, Glasgow, UK.

ORCID-Profile: Su An, Tian-Rui Xu

Förderung

  • National Natural Science Foundation of China (NSFC)
  • Yunnan Major Scientific and Technological Projects
  • Key Fund of Yunnan Basic Research Program
  • National Key Research and Development Project

Zitieren

APA

Wang, J., Su, H., Wang, M., Ward, R., An, S., & Xu, T. R. (2025). Pyroptosis and the fight against lung cancer. Medicinal Research Reviews, 45(1), 5-28. https://doi.org/10.1002/med.22071

Vancouver

Wang J, Su H, Wang M, Ward R, An S, Xu TR. Pyroptosis and the fight against lung cancer. Medicinal Research Reviews. 2025;45(1):5-28. doi:10.1002/med.22071

BibTeX
@article{Wang2025,
  author = {Wang, Jiwei and Su, Huiling and Wang, Min and Ward, Richard and An, Su and Xu, Tian-Rui},
  title = {Pyroptosis and the fight against lung cancer},
  journal = {Medicinal Research Reviews},
  year = {2025},
  volume = {45},
  number = {1},
  pages = {5--28},
  doi = {10.1002/med.22071}
}
Kostenlos starten →